Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 9
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Tefferi A, Loscocco GG, Farrukh F, Szuber N, Mannelli F, Pardanani A, Hanson CA, Ketterling RP, De Stefano V, Carobbio A, Barbui T, Guglielmelli P, Gangat N, Vannucchi AM. Tefferi A, et al. Among authors: farrukh f. Am J Hematol. 2023 Dec;98(12):1829-1837. doi: 10.1002/ajh.27079. Epub 2023 Sep 4. Am J Hematol. 2023. PMID: 37665758
Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia.
Gangat N, Johnson I, McCullough K, Farrukh F, Al-Kali A, Alkhateeb H, Begna K, Mangaonkar A, Litzow M, Hogan W, Shah M, Patnaik M, Pardanani A, Tefferi A. Gangat N, et al. Among authors: farrukh f. Haematologica. 2022 Oct 1;107(10):2501-2505. doi: 10.3324/haematol.2022.281214. Haematologica. 2022. PMID: 35770533 Free PMC article. No abstract available.
Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents.
Johnson IM, Bezerra ED, Farrukh F, McCullough K, Al-Kali A, Alkhateeb HB, Begna K, Litzow MR, Hogan WJ, Shah MV, Patnaik MM, Tefferi A, Gangat N. Johnson IM, et al. Among authors: farrukh f. Blood Adv. 2022 Sep 13;6(17):5227-5231. doi: 10.1182/bloodadvances.2022007333. Blood Adv. 2022. PMID: 35358999 Free PMC article. No abstract available.
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events.
Gangat N, Szuber N, Jadoon Y, Farrukh F, Begna K, Elliott MA, Wolanskyj-Spinner AP, Hanson CA, Pardanani AD, De Stefano V, Barbui T, Vannucchi AM, Tefferi A. Gangat N, et al. Among authors: farrukh f. Blood Adv. 2022 Jul 12;6(13):3835-3839. doi: 10.1182/bloodadvances.2022007023. Blood Adv. 2022. PMID: 35271689 Free PMC article. No abstract available.
12 results